Logo image of BTRS

BTRS HOLDINGS INC-CL 1 (BTRS) Stock Fundamental Analysis

USA - NASDAQ:BTRS - US11778X1046 - Common Stock

9.49 USD
-0.01 (-0.11%)
Last: 12/15/2022, 8:00:02 PM
9.49 USD
0 (0%)
After Hours: 12/15/2022, 8:00:02 PM
Fundamental Rating

2

Overall BTRS gets a fundamental rating of 2 out of 10. We evaluated BTRS against 284 industry peers in the Software industry. While BTRS seems to be doing ok healthwise, there are quite some concerns on its profitability. BTRS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BTRS had negative earnings in the past year.
In the past year BTRS has reported a negative cash flow from operations.
BTRS Yearly Net Income VS EBIT VS OCF VS FCFBTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 0 -20M -40M -60M

1.2 Ratios

BTRS has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BTRS Yearly ROA, ROE, ROICBTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 0 -5 -10 -15

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BTRS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BTRS Yearly Profit, Operating, Gross MarginsBTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

BTRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
BTRS has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, BTRS has a worse debt to assets ratio.
BTRS Yearly Shares OutstandingBTRS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 50M 100M 150M
BTRS Yearly Total Debt VS Total AssetsBTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 100M 200M 300M 400M

2.2 Solvency

BTRS has an Altman-Z score of 5.05. This indicates that BTRS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.05, BTRS is in the better half of the industry, outperforming 77.67% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that BTRS is not too dependend on debt financing.
BTRS has a better Debt to Equity ratio (0.00) than 62.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.05
ROIC/WACCN/A
WACC10.26%
BTRS Yearly LT Debt VS Equity VS FCFBTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.15 indicates that BTRS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.15, BTRS is in line with its industry, outperforming 57.67% of the companies in the same industry.
BTRS has a Quick Ratio of 2.15. This indicates that BTRS is financially healthy and has no problem in meeting its short term obligations.
BTRS has a Quick ratio (2.15) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 2.15
BTRS Yearly Current Assets VS Current LiabilitesBTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 50M 100M 150M 200M 250M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BTRS have decreased strongly by -31.58% in the last year.
Looking at the last year, BTRS shows a very strong growth in Revenue. The Revenue has grown by 53.12%.
EPS 1Y (TTM)-31.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.71%
Revenue 1Y (TTM)53.12%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%24.19%

3.2 Future

BTRS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.45% yearly.
The Revenue is expected to grow by 18.43% on average over the next years. This is quite good.
EPS Next Y-18.52%
EPS Next 2Y17.4%
EPS Next 3Y14.59%
EPS Next 5Y2.45%
Revenue Next Year29.05%
Revenue Next 2Y25.59%
Revenue Next 3Y23.81%
Revenue Next 5Y18.43%

3.3 Evolution

BTRS Yearly Revenue VS EstimatesBTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
BTRS Yearly EPS VS EstimatesBTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BTRS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BTRS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BTRS Price Earnings VS Forward Price EarningsBTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BTRS Per share dataBTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

BTRS's earnings are expected to grow with 14.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.4%
EPS Next 3Y14.59%

More info and screens

0

5. Dividend

5.1 Amount

BTRS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BTRS HOLDINGS INC-CL 1

NASDAQ:BTRS (12/15/2022, 8:00:02 PM)

After market: 9.49 0 (0%)

9.49

-0.01 (-0.11%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07 2022-11-07/bmo
Earnings (Next)02-27 2023-02-27
Inst Owners0%
Inst Owner Change0%
Ins Owners0.23%
Ins Owner Change0%
Market Cap1.56B
Revenue(TTM)189.15M
Net Income(TTM)-81923000
Analysts75
Price Target10.2 (7.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-49.28%
Min EPS beat(2)-67.7%
Max EPS beat(2)-30.85%
EPS beat(4)0
Avg EPS beat(4)-72.74%
Min EPS beat(4)-163.39%
Max EPS beat(4)-29%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)16.54%
Min Revenue beat(2)15.28%
Max Revenue beat(2)17.8%
Revenue beat(4)4
Avg Revenue beat(4)19.88%
Min Revenue beat(4)15.28%
Max Revenue beat(4)27.07%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)7.4%
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.24%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.26
P/FCF N/A
P/OCF N/A
P/B 6.21
P/tB 16.68
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS1.15
BVpS1.53
TBVpS0.57
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.27%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 2.15
Altman-Z 5.05
F-Score2
WACC10.26%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.71%
EPS Next Y-18.52%
EPS Next 2Y17.4%
EPS Next 3Y14.59%
EPS Next 5Y2.45%
Revenue 1Y (TTM)53.12%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%24.19%
Revenue Next Year29.05%
Revenue Next 2Y25.59%
Revenue Next 3Y23.81%
Revenue Next 5Y18.43%
EBIT growth 1Y-68.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.16%
EBIT Next 3Y29.57%
EBIT Next 5Y15.55%
FCF growth 1Y-3547.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3371.36%
OCF growth 3YN/A
OCF growth 5YN/A

BTRS HOLDINGS INC-CL 1 / BTRS FAQ

What is the ChartMill fundamental rating of BTRS HOLDINGS INC-CL 1 (BTRS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BTRS.


Can you provide the valuation status for BTRS HOLDINGS INC-CL 1?

ChartMill assigns a valuation rating of 1 / 10 to BTRS HOLDINGS INC-CL 1 (BTRS). This can be considered as Overvalued.


How profitable is BTRS HOLDINGS INC-CL 1 (BTRS) stock?

BTRS HOLDINGS INC-CL 1 (BTRS) has a profitability rating of 0 / 10.


What is the financial health of BTRS HOLDINGS INC-CL 1 (BTRS) stock?

The financial health rating of BTRS HOLDINGS INC-CL 1 (BTRS) is 6 / 10.


Can you provide the expected EPS growth for BTRS stock?

The Earnings per Share (EPS) of BTRS HOLDINGS INC-CL 1 (BTRS) is expected to decline by -18.52% in the next year.